12:00 AM
 | 
Jan 11, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Acton, Forest Laboratories sales and marketing update

Acton received exclusive, worldwide rights to develop and commercialize Forest's Aerospan flunisolide. Forest will receive an undisclosed upfront payment and is...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >